NVDA vs TLS

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

Telos Corporation exhibits a critical divergence between explosive top-line growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While YoY revenue growth of 77.4% is impressive, the company remains unprofitable with a -22.17% profit margin and negative ROE. This fundamental weakness is compounded by a strong bearish insider signal, with the CEO, CFO, and General Counsel all selling significant positions. Despite a positive analyst target price of $7.00, the deterministic health metrics and insider activity suggest high risk.